The news: Epic launched a new program to improve clinical trial matchmaking in underserved populations, dubbed Life Sciences.
Epic’s Cosmos database of more than 160 million patient electronic health records (EHRs) provides customized data queries to help healthcare providers make recommendations on which patients should participate in trials. “We use Cosmos to run trial feasibility and matchmaking queries, which provider organizations can then re-run on their databases, identify their possible patient participants, and choose how to engage with them for potential studies,” Alan Hutchison, vice president at Epic, told Insider Intelligence. “All of this is possible through Epic.”
The problem: Disconnected systems create inefficiencies such as duplication efforts that lead to patients and providers being unable to participate in trials. To improve clinical participation in trials and accelerate drug development, the healthcare industry needs a stronger link to clinical data. Epic is a “single codebase that connects clinicians, patients, payers, and specialty diagnostics labs—and eventually industry sponsors—throughout the healthcare ecosystem,” Hutchison said.
Trendspotting: Increasing participation in clinical trials will be key considering the low numbers of people that participate and the lack of diversity in trials.
Epic isn’t the only EHR company to be addressing clinical trial access.
Pharma companies are also working on boosting clinical trial participation.
The big takeaway: Data-driven programs like Epic Life Sciences can build more representation into clinical trials and increase coordination among patients, providers, and trial sponsors.
This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.
Want to learn more about how you can benefit from our expert analysis? Click here.
11 Times SquareNew York, NY 100361-800-405-0844